Clinical Trials on Metastatic Prostatic Adenocarcinoma in Japan
Total 594 results
-
Kindai UniversityJanssen Pharmaceutical K.K.RecruitingMetastatic Castration-sensitive Prostate CancerJapan
-
Translational Research Center for Medical Innovation...Kyoto University, Graduate School of MedicineCompletedProstate Cancer | Metastatic CancerJapan
-
Taro Iguchi, MD, PHDBayer Yakuhin, Ltd.Active, not recruitingBone Metastases | Castration-resistant Prostate CancerJapan
-
BayerRecruitingMetastatic Hormone-sensitive Prostate Cancer (mHSPC)Japan
-
Janssen Pharmaceutical K.K.CompletedMetastatic Castration-Resistant Prostate CancerJapan
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaActive, not recruitingProstatic Neoplasms | Metastatic Castration-Resistant Prostate CancerJapan
-
ExelixisTakeda; Roche-GenentechActive, not recruitingMetastatic Prostate Cancer | Prostate AdenocarcinomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Russian Federation, Singapore, Spain, ... and more
-
Taro Iguchi, MD, PHDAstellas Pharma IncCompleted
-
TakedaCompleted
-
Translational Research Center for Medical Innovation...Jikei University School of MedicineCompleted
-
Astellas Pharma IncMedivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate Cancer | Prostate Neoplasms | Castration Resistant Prostate Cancer (CRPC)Japan
-
Iwate Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknown
-
Norio NonomuraUnknownCastration Resistant Prostate CancerJapan
-
Astellas Pharma IncCompletedBenign Prostate HyperplasiaJapan
-
Japan Study Group of Prostate CancerEnrolling by invitation
-
AstraZenecaCompletedEGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.Italy, Spain, United Kingdom, Sweden, Japan, Netherlands, Germany, France
-
Zeria PharmaceuticalCompletedMetastatic Pancreatic AdenocarcinomaJapan, Korea, Republic of, Taiwan
-
Kyowa Kirin, Inc.RecruitingGastric Adenocarcinoma | Non Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Esophageal Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaJapan
-
Institut de Recherches Internationales ServierNot yet recruitingMetastatic Adenocarcinoma of the PancreasJapan
-
BayerOrion Corporation, Orion PharmaCompletedProstate Cancer Non-Metastatic | Castration-ResistantBelgium, France, Poland, Spain, Canada, United States, Estonia, Portugal, Taiwan, Japan, Russian Federation, Finland, Germany, Austria, Czechia, Hungary, Australia, Brazil, South Africa, Latvia, Italy, United Kingdom, Turkey, Serbia, Ro... and more
-
AmgenCompletedProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Austria, Singapore, Australia, Netherlands, France, Japan, Taiwan, Canada
-
Translational Research Center for Medical Innovation...The Jikei University School of MedicineCompleted
-
AstraZenecaCompleted
-
Osamu UkimuraActive, not recruiting
-
Astellas Pharma IncCompletedProstate CancerJapan
-
Bristol-Myers SquibbCompleted
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstate Cancer MetastaticCanada, Germany, United States, Israel, Puerto Rico, Taiwan, Korea, Republic of, Australia, Chile, China, France, Norway, Czechia, Finland, Hong Kong, Netherlands, Poland, Spain, Sweden, Turkey, Denmark, Hungary, Italy, United Kingdom, ... and more
-
Hoffmann-La RocheActive, not recruitingMetastatic Prostate CancerUnited States, Belgium, France, United Kingdom, Canada, Korea, Republic of, China, Denmark, Greece, Ireland, Portugal, Spain, Italy, Brazil, Mexico, Australia, Thailand, Japan, Costa Rica, Israel, Russian Federation, Austria, Hungary, Norwa... and more
-
Millennium Pharmaceuticals, Inc.TerminatedMetastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Recurrent Gastric Adenocarcinoma | Recurrent Gastroesophageal Junction Adenocarcinoma | Advanced Gastrointestinal Carcinoma | Recurrent Gastrointestinal CarcinomaTaiwan, Korea, Republic of, Japan
-
ServierActive, not recruitingCholangiocarcinoma Non-resectable | Cholangiocarcinoma MetastaticJapan
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States, Italy, Spain, Belgium, Canada, France, Korea, Republic of, United Kingdom, Brazil, Czechia, Turkey, Australia, Chile, Germany, Japan, Netherlands, Slovakia
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetics, Inc.; Foundation Medicine, Inc.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Canada, Denmark, Germany, Italy, Netherlands, Norway, Spain, Argentina, Taiwan, France, Korea, Republic of, Brazil, Japan, Turkey, United Kingdom, Austria, Australia, Israel, Sweden
-
Kyushu UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstatic Neoplasms | Metastatic Castration-resistant Prostate Cancer (mCRPC)Australia, Germany, United States, Puerto Rico, Israel, Korea, Republic of, Taiwan, China, Costa Rica, Guatemala, Spain, France, Hong Kong, Portugal, Romania, Chile, Czechia, Hungary, Italy, Sweden, Turkey, United Kingdom, Estonia, Ir... and more
-
Translational Research Center for Medical Innovation...Kagawa UniversityCompleted
-
TakedaCompletedHormone Treatment-naïve Participants With Prostate CancerJapan
-
Johnson & Johnson International (Singapore) Pte...CompletedHigh Risk Localized Prostate CancerJapan, Korea, Republic of, Taiwan
-
Novartis PharmaceuticalsCompletedCastration-resistant Prostate Cancer, Advanced Breast CancerJapan
-
Janssen Research & Development, LLCCompleted
-
SanofiCompletedBenign Prostatic HyperplasiaJapan
-
Janssen Research & Development, LLCCompleted
-
Tokyo Medical and Dental UniversityRecruitingBreast Cancer | Metastatic Breast Cancer | OligometastasisJapan
-
SanofiCompletedTherapy, Prostatic NeoplasmsJapan
-
Kissei Pharmaceutical Co., Ltd.Completed
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingMetastatic Hormone Sensitive Prostate CancerKorea, Republic of, Japan, United States, Argentina, Australia, Belgium, Canada, Chile, Denmark, Finland, France, Germany, Israel, Italy, Netherlands, New Zealand, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, United...
-
SanofiCompletedBenign Prostatic HyperplasiaJapan
-
BayerOrion Corporation, Orion PharmaCompletedMetastatic Hormone-sensitive Prostate CancerBelgium, France, Sweden, China, Canada, United States, Spain, Taiwan, Japan, Finland, Korea, Republic of, Australia, Brazil, Czechia, Israel, Italy, Netherlands, Russian Federation, Bulgaria, United Kingdom, Germany, Poland, Mexico
-
Eli Lilly and CompanyCompletedNon-Hodgkin's Lymphoma | Solid Tumor | Metastatic Cancer | Cholangiocarcinoma | Advanced Cancer | Biliary Tract Carcinoma | Gall Bladder CarcinomaJapan
-
City of Hope Medical CenterRecruitingCholangiocarcinoma | Cholangiocarcinoma, Intrahepatic | Cholangiocarcinoma Resectable | Cholangiocarcinoma; LiverUnited States, Japan
-
AstraZenecaRecruitingMetastatic Castration-Sensitive Prostate CancerUnited States, Canada, Spain, United Kingdom, Italy, Australia, Korea, Republic of, Belgium, Germany, Japan, Peru, France, China, India, Taiwan, Thailand, Austria, Brazil, Turkey, Malaysia, Finland, Netherlands, Chile, Hungary, Poland, Sw...